Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Experience Profiling of Fluorescence-Guided Surgery II: Non-Glioma Pathologies.

Ji SY, Kim JW, Park CK.

Brain Tumor Res Treat. 2019 Oct;7(2):105-111. doi: 10.14791/btrt.2019.7.e39.

2.

Experience Profiling of Fluorescence-Guided Surgery I: Gliomas.

Ji SY, Kim JW, Park CK.

Brain Tumor Res Treat. 2019 Oct;7(2):98-104. doi: 10.14791/btrt.2019.7.e38.

3.

Impact of 5-aminolevulinic acid fluorescence-guided surgery on the extent of resection of meningiomas--with special regard to high-grade tumors.

Cornelius JF, Slotty PJ, Kamp MA, Schneiderhan TM, Steiger HJ, El-Khatib M.

Photodiagnosis Photodyn Ther. 2014 Dec;11(4):481-90. doi: 10.1016/j.pdpdt.2014.07.008. Epub 2014 Aug 10.

PMID:
25117928
4.

What is the Surgical Benefit of Utilizing 5-Aminolevulinic Acid for Fluorescence-Guided Surgery of Malignant Gliomas?

Hadjipanayis CG, Widhalm G, Stummer W.

Neurosurgery. 2015 Nov;77(5):663-73. doi: 10.1227/NEU.0000000000000929. Review.

5.

Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma.

Tsugu A, Ishizaka H, Mizokami Y, Osada T, Baba T, Yoshiyama M, Nishiyama J, Matsumae M.

World Neurosurg. 2011 Jul-Aug;76(1-2):120-7. doi: 10.1016/j.wneu.2011.02.005.

PMID:
21839963
6.

Use of fluorescence to guide resection or biopsy of primary brain tumors and brain metastases.

Marbacher S, Klinger E, Schwyzer L, Fischer I, Nevzati E, Diepers M, Roelcke U, Fathi AR, Coluccia D, Fandino J.

Neurosurg Focus. 2014 Feb;36(2):E10. doi: 10.3171/2013.12.FOCUS13464.

PMID:
24484248
7.

Analysis of 5-aminolevulinic acid-induced fluorescence in 55 different spinal tumors.

Millesi M, Kiesel B, Woehrer A, Hainfellner JA, Novak K, Martínez-Moreno M, Wolfsberger S, Knosp E, Widhalm G.

Neurosurg Focus. 2014 Feb;36(2):E11. doi: 10.3171/2013.12.FOCUS13485.

PMID:
24484249
8.

Finding the anaplastic focus in diffuse gliomas: the value of Gd-DTPA enhanced MRI, FET-PET, and intraoperative, ALA-derived tissue fluorescence.

Ewelt C, Floeth FW, Felsberg J, Steiger HJ, Sabel M, Langen KJ, Stoffels G, Stummer W.

Clin Neurol Neurosurg. 2011 Sep;113(7):541-7. doi: 10.1016/j.clineuro.2011.03.008. Epub 2011 Apr 20.

PMID:
21507562
9.

The impact of fluorescence guidance on spinal intradural tumour surgery.

Eicker SO, Floeth FW, Kamp M, Steiger HJ, Hänggi D.

Eur Spine J. 2013 Jun;22(6):1394-401. doi: 10.1007/s00586-013-2657-0. Epub 2013 Jan 10.

10.

5-ALA fluorescence on tumors different from malignant gliomas. Review of the literature and our experience.

Boschi A, Della Puppa A.

J Neurosurg Sci. 2019 Dec;63(6):661-669. doi: 10.23736/S0390-5616.19.04766-0. Epub 2019 Jul 29.

PMID:
31355622
11.
12.

Established and emerging uses of 5-ALA in the brain: an overview.

Díez Valle R, Hadjipanayis CG, Stummer W.

J Neurooncol. 2019 Feb;141(3):487-494. doi: 10.1007/s11060-018-03087-7. Epub 2019 Jan 3. Review.

PMID:
30607705
13.

Maximizing safe resections: the roles of 5-aminolevulinic acid and intraoperative MR imaging in glioma surgery-review of the literature.

Suero Molina E, Schipmann S, Stummer W.

Neurosurg Rev. 2019 Jun;42(2):197-208. doi: 10.1007/s10143-017-0907-z. Epub 2017 Sep 18. Review.

14.

5-Aminolevulinic acid fluorescence guided surgery for recurrent high-grade gliomas.

Chohan MO, Berger MS.

J Neurooncol. 2019 Feb;141(3):517-522. doi: 10.1007/s11060-018-2956-8. Epub 2018 Aug 10. Review.

PMID:
30097823
15.

A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.

Lau D, Hervey-Jumper SL, Chang S, Molinaro AM, McDermott MW, Phillips JJ, Berger MS.

J Neurosurg. 2016 May;124(5):1300-9. doi: 10.3171/2015.5.JNS1577. Epub 2015 Nov 6.

PMID:
26544781
16.

Quantification of PpIX-fluorescence of cerebral metastases: a pilot study.

Knipps J, Fischer I, Neumann LM, Rapp M, Dibué-Adjei M, Freiin von Saß C, Placke JM, Mijderwijk HJ, Steiger HJ, Sabel M, Cornelius JF, Kamp MA.

Clin Exp Metastasis. 2019 Oct;36(5):467-475. doi: 10.1007/s10585-019-09986-x. Epub 2019 Aug 2.

PMID:
31376098
17.

The current status of 5-ALA fluorescence-guided resection of intracranial meningiomas-a critical review.

Motekallemi A, Jeltema HR, Metzemaekers JD, van Dam GM, Crane LM, Groen RJ.

Neurosurg Rev. 2015 Oct;38(4):619-28. doi: 10.1007/s10143-015-0615-5. Epub 2015 Mar 5. Review.

18.

Fluorescence Diagnosis in Neurooncology: Retrospective Analysis of 653 Cases.

Goryaynov SA, Okhlopkov VA, Golbin DA, Chernyshov KA, Svistov DV, Martynov BV, Kim AV, Byvaltsev VA, Pavlova GV, Batalov A, Konovalov NA, Zelenkov PV, Loschenov VB, Potapov AA.

Front Oncol. 2019 Sep 6;9:830. doi: 10.3389/fonc.2019.00830. eCollection 2019.

19.

5-Aminolevulinic acid fluorescence-guided surgery for spinal cord melanoma metastasis: a technical note.

Ruschel LG, Ramina R, da Silva EB Jr, Cavalcanti MS, Duarte JFS.

Acta Neurochir (Wien). 2018 Oct;160(10):1905-1908. doi: 10.1007/s00701-018-3645-2. Epub 2018 Aug 9.

PMID:
30091052
20.

Characterization of plasma-derived protoporphyrin-IX-positive extracellular vesicles following 5-ALA use in patients with malignant glioma.

Jones PS, Yekula A, Lansbury E, Small JL, Ayinon C, Mordecai S, Hochberg FH, Tigges J, Delcuze B, Charest A, Ghiran I, Balaj L, Carter BS.

EBioMedicine. 2019 Oct;48:23-35. doi: 10.1016/j.ebiom.2019.09.025. Epub 2019 Oct 15.

Supplemental Content

Support Center